Optum and Syneos Health Partner to Advance an Adaptive Clinical Development Model
Globe Newswire•20/10/2026•09:00 ET
0
Key Highlights
- ➤Optum and Syneos Health partner on adaptive clinical development model
- ➤Syneos Health becomes Optum’s preferred site management organization development partner
- ➤Collaboration targets faster recruitment and more predictable trial timelines and costs
- ➤Model combines Optum AI resources with Syneos global trial operations
- ➤Costa Panagos says connected data, expertise and AI can improve trial decisions
Expert Statements
Costa Panagos, Chief Executive Officer of Syneos Health
“Clinical development is at an inflection point. The future belongs to organizations that can connect data, human expertise and AI technology to make better decisions faster”
Costa Panagos, Chief Executive Officer of Syneos Health
“Our collaboration with Optum brings deep healthcare expertise that can help improve trial design and implementation with greater precision and predictability.”
Sandeep Dadlani, Chief Executive Officer of Optum Insight
“Clinical research is one of the most complex and data-intensive activities in healthcare, yet necessary connections are fragmented all too often.”
Sandeep Dadlani, Chief Executive Officer of Optum Insight
“By connecting our responsible use of technology and network with Syneos Health’s global clinical development capabilities, we can make the health system work better for everyone.”
Partnership Will Transform How Clinical Development is Designed and Executed
MORRISVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced a partnership with Optum to build a more adaptive and connected model for clinical development, helping biopharmaceutical companies deliver promising therapies to patients sooner.
Get started
Create a free account to read the full story.